Vildagliptin reduces cardiac ischemic-reperfusion injury in obese orchiectomized rats
© 2016 Society for Endocrinology. Obesity and testosterone deprivation are associated with coronary artery disease. Testosterone and vildagliptin (dipeptidyl peptidase-4 inhibitors) exert cardioprotection during ischemic-reperfusion (I/R) injury. However, the effect of these drugs on I/R heart in a...
Saved in:
Main Authors: | Pongkan W., Pintana H., Jaiwongkam T., Kredphoo S., Sivasinprasasn S., Chattipakorn S., Chattipakorn N. |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84991497391&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/42318 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Vildagliptin reduces cardiac ischemic-reperfusion injury in obese orchiectomized rats
by: Wanpitak Pongkan, et al.
Published: (2018) -
Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury
by: Pongpan Tanajak, et al.
Published: (2018) -
Estrogenic Impact on Cardiac Ischemic/Reperfusion Injury
by: Sivasinprasasn S., et al.
Published: (2017) -
DPP-4 inhibitor and estrogen share similar efficacy against cardiac ischemic-reperfusion injury in obese-insulin resistant and estrogen-deprived female rats
by: Sivasinprasasn S., et al.
Published: (2017) -
Estrogenic Impact on Cardiac Ischemic/Reperfusion Injury
by: Sivaporn Sivasinprasasn, et al.
Published: (2018)